⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqCM

LQDA

Liquidia Corporation

Healthcare · Drug Manufacturers - Specialty & Generic

42.65USD

+2.9600 (+7.46%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗

Computing valuation metrics…

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on LQDA.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.

Valuation

P/E (TTM)

27.54x

P/E (Forward)

19.50x

EV/EBITDA

21.86x

EV/Revenue

8.24x

P/S (TTM)

8.47x

P/B

19.57x

FCF Yield

3.95%

Dividend Yield

0.00%

Gross Margin

1.82%

Operating Margin

37.39%

Net Margin

30.74%

Peer Comparison — Drug Manufacturers - Specialty & Generic

CompanyMkt CapP/EEV/EBITDAFCF YieldRev GrowthDiv Yield
LQDALiquidia Corporation$3.82B27.54x21.86x3.95%1842.73%0.00%
TEVATeva Pharmaceutical Industries Limited$45.96B65.68x13.86x4.83%-0.80%0.00%

Subject metrics from SEC filings where available; peer metrics from cached market data.

ZTSZoetis Inc.
$33.48B
13.33x
10.10x
6.02%
-0.20%
2.62%
UTHRUnited Therapeutics Corporation$25.20B21.04x15.06x2.21%-1.90%0.00%
VTRSViatris Inc.$20.67B—7.64x12.95%4.90%2.67%
HIMSHims & Hers Health, Inc.$6.47B——13.14%38.20%0.00%
KNSAKiniksa Pharmaceuticals International, plc$5.90B77.51x53.60x2.14%55.40%0.00%
RGCRegencell Bioscience Holdings Limited$3.80B——-0.08%—0.00%
AMLXAmylyx Pharmaceuticals, Inc.$3.41B——-2.26%—0.00%